Investigating the Dynamics of Patient Engagement and Trends in Participation in Recurrent Prostate Cancer Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Number of patients who decide to participate in a recurrent prostate cancer clinical research
研究概览
简要总结
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition.
These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patient is at least 18 years of age
- •Diagnosis of recurrent prostate cancer
- •Ability to understand and the willingness to sign a written informed consent document
排除标准
- •Enrolled in another research study
- •Patients with psychiatric illness/social situations that would limit compliance with study requirements
- •Inability to provide written informed consent
结局指标
主要结局
Number of patients who decide to participate in a recurrent prostate cancer clinical research
时间窗: 3 months
Rate of patients who remain in recurrent prostate cancer clinical research to trial completion
时间窗: 12 months
次要结局
未报告次要终点